Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Exercise Test × 30 days × Clear all

Sponsor

Conditions

Lung Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Obesity 1 Lymphoma, Non-Hodgkin 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Hematopoietic and Lymphatic System Neoplasm 1 Heart Defects, Congenital 1 Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1 Carcinoma, Transitional Cell 1

Interventions

Carboplatin 7 pembrolizumab 6 Cisplatin 6 Radiotherapy 5 Cetuximab 5 Paclitaxel 4 Drug Therapy 3 toripalimab 2 osimertinib 2 fludarabine 2 X-Rays 2 Fulvestrant 2 Fluorouracil 2 Cyclophosphamide 2 Chemoradiotherapy 2 trastuzumab deruxtecan 1 tisotumab vedotin 1 tislelizumab 1 ribociclib 1 pralsetinib 1 pamiparib 1 palbociclib 1 monalizumab 1 exemestane 1 entrectinib 1 disitamab vedotin 1 Therapeutics 1 Tablets 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡